Overview

Hypertonic Saline Solution to Prevent Acute Kidney Injury After Heart Transplantation

Status:
Not yet recruiting
Trial end date:
2025-07-01
Target enrollment:
0
Participant gender:
All
Summary
The goal of this study is to evaluate if hypertonic saline solution can prevent or attenuate acute kidney injury after heart transplantation in the early postoperative phase.
Phase:
Phase 2
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Fernando Bacal
Treatments:
Pharmaceutical Solutions
Criteria
Inclusion Criteria:

- Hospitalized patients submitted to orthotopic heart transplantation (HT)

Exclusion Criteria:

- Requirement of renal replacement therapy before HT

- Requirement of extracorporeal membrane oxygenation (ECMO) before HT

- Double transplant (e.g. heart-kidney or heart-lung)

- Hypernatremia (Na ≥ 145)

- Moderate or severe hyponatremia (Na ≤ 120)